Literature DB >> 8667859

Raltitrexed, a new drug for advanced colorectal cancer.

G M Mead1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8667859     DOI： 10.1016/s0140-6736(96)91068-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Increasing age-related survival gap among patients with colorectal cancer: a population-based retrospective study.

Authors:  Yang Feng; Shaobo Mo; Weixing Dai; Qingguo Li; Guoxiang Cai; Sanjun Cai
Journal:  Int J Clin Oncol       Date:  2019-09-17       Impact factor: 3.402

2.  A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143).

Authors:  José María Viéitez; Manuel Valladares; Ignacio Peláez; Luis de Sande González; Jesús García-Foncillas; José Luis García-López; Carlos García-Girón; Margarita Reboredo; Humberto Bovio; Angel Jiménez Lacave
Journal:  Invest New Drugs       Date:  2010-03-06       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.